Valbiotis SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 1.51 million compared to EUR 0.748 million a year ago. Net loss was EUR 5.1 million compared to EUR 3.47 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 EUR | +0.49% | +5.90% | -17.40% |
Apr. 26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.40% | 70.17M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ALVAL Stock
- News VALBIOTIS
- Valbiotis SA Reports Earnings Results for the Half Year Ended June 30, 2022